Search results
Showing 1 to 15 of 1358 results for patients and public
Members are appointed for a 3-year term, and are drawn from: the NHS patient and carer organisations academia pharmaceuticals and...
Evidence-based recommendations on lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema in adults. This involves diverting some of the lymphatic vessels around where lymph nodes have been removed to nearby veins.
View recommendations for IPG785Show all sections
NICE research projects and partners.
Details, meeting dates and minutes of the independent technology appraisal committees
Biographies of the NICE executive team and minutes of their meetings
Find out more about NICE technology appraisals advisory committee D members
commentators. Consultee organisations include: national groups representing patients and carers bodies representing healthcare...
GaitSmart rehabilitation exercise programme for gait and mobility issues (MTG78)
Evidence-based recommendations on GaitSmart rehabilitation exercise programme for gait and mobility issues in adults.
View recommendations for MTG78Show all sections
working closely across all tiers of the trust to improve the delivery of safe patient care. He is also the Acute Care Common Stem...
An outline of the roles and responsibilities of the National Institute for Health and Care Excellence
Ovarian cancer: identifying and managing familial and genetic risk (NG241)
This guideline covers assessing the familial and genetic risk of having a pathogenic variant associated with ovarian cancer in adults.
Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management (NG240)
This guideline covers recognising, diagnosing and managing bacterial meningitis and meningococcal disease in babies, children, young people and adults. It aims to reduce death and disability by helping healthcare professionals recognise meningitis and treat it quickly and effectively.
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)
Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.
Resources to help organisations who want to help develop NICE guidance